Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
5.28
+0.05 (0.96%)
Nov 20, 2024, 4:00 PM EST - Market closed

Outlook Therapeutics Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 2018 - 2014
Revenue
-----8.15
Upgrade
Revenue Growth (YoY)
-----163.84%
Upgrade
Cost of Revenue
34.1826.4542.3338.9626.3423.81
Upgrade
Gross Profit
-34.18-26.45-42.33-38.96-26.34-15.66
Upgrade
Selling, General & Admin
27.126.6720.7412.779.979.37
Upgrade
Operating Expenses
27.126.6720.7412.779.979.37
Upgrade
Operating Income
-61.28-53.13-63.07-51.73-36.31-25.03
Upgrade
Interest Expense
-2.19-1.56-1.49-0.94-1.76-3.47
Upgrade
Earnings From Equity Investments
-0.09-0.01-0.05-0.05--
Upgrade
Other Non Operating Income (Expenses)
-27.690.050.47-0.451.982.44
Upgrade
EBT Excluding Unusual Items
-91.25-54.65-64.14-53.16-36.09-26.06
Upgrade
Asset Writedown
-----0.53-11.27
Upgrade
Other Unusual Items
-2.79-4.33-1.91--1.9-0.61
Upgrade
Pretax Income
-94.05-58.98-66.05-53.16-38.51-37.93
Upgrade
Income Tax Expense
0000-3.27-3.41
Upgrade
Earnings From Continuing Operations
-94.05-58.98-66.05-53.16-35.24-34.52
Upgrade
Net Income
-94.05-58.98-66.05-53.16-35.24-34.52
Upgrade
Preferred Dividends & Other Adjustments
----13.631.52
Upgrade
Net Income to Common
-94.05-58.98-66.05-53.16-48.87-36.04
Upgrade
Shares Outstanding (Basic)
161311841
Upgrade
Shares Outstanding (Diluted)
161311841
Upgrade
Shares Change (YoY)
32.01%17.96%38.91%110.43%298.84%268.84%
Upgrade
EPS (Basic)
-5.93-4.72-6.23-6.96-13.47-39.62
Upgrade
EPS (Diluted)
-5.93-4.72-6.23-6.96-13.47-39.62
Upgrade
Free Cash Flow
-64.55-42.97-56.67-54.25-31.79-32.73
Upgrade
Free Cash Flow Per Share
-4.07-3.44-5.34-7.11-8.76-35.98
Upgrade
Gross Margin
------192.23%
Upgrade
Operating Margin
------307.25%
Upgrade
Profit Margin
------442.41%
Upgrade
Free Cash Flow Margin
------401.75%
Upgrade
EBITDA
-61.19-53.08-62.87-51.46-35.76-21.67
Upgrade
EBITDA Margin
------265.98%
Upgrade
D&A For EBITDA
0.10.040.20.260.553.36
Upgrade
EBIT
-61.28-53.13-63.07-51.73-36.31-25.03
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.